miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction

Maya E Woodbury1, Robert W Freilich2, Christopher J Cheng3

  • 1Department of Pharmacology and Experimental Therapeutics and Graduate Program in Neuroscience, Boston University, Boston, Massachusetts 02118, and.

Insights

MicroRNA-155 (miR-155) drives inflammation-induced neurogenesis deficits by activating microglia and inducing IL6. Inhibiting miR-155 or IL6 restores normal neural development.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Biology

Background:

  • Inflammation impacts neurogenesis, but mechanisms are unclear.
  • MicroRNAs (miRs) regulate inflammatory and neural processes.
  • miR-155 is upregulated in microglia during inflammation.

Purpose of the Study:

  • Investigate miR-155's role in inflammation-induced neurogenesis deficits.
  • Elucidate miR-155's mechanism in microglial activation and IL6 induction.
  • Determine miR-155's sufficiency in disrupting hippocampal development.

Main Methods:

  • In vitro studies using lipopolysaccharide (LPS)-stimulated microglia and neural stem cells (NSCs).
  • Genetic manipulation: miR-155 knockout mice and transgenic mice with elevated miR-155.
  • In vivo assessments of neurogenesis, microglial activation, and hippocampal morphology.

Main Results:

  • miR-155 is crucial for LPS-induced IL6 production in microglia.
  • Microglial activation and IL6 mediate inflammation-induced neurogenic deficits.
  • miR-155 knockout reversed LPS-induced neurogenic deficits and microglial activation.
  • Elevated miR-155 in stem cells disrupted hippocampal development, increasing proliferation and causing ectopic neuron/glia localization.

Conclusions:

  • miR-155 is essential for inflammation-induced neurogenic deficits via microglial IL6 induction.
  • miR-155 dysregulation is sufficient to disrupt normal hippocampal development.
  • Targeting miR-155 may offer therapeutic potential for neuroinflammatory conditions.